Notice to Investors Regarding 2011 and 2015 Guidance Read more about Notice to Investors Regarding 2011 and 2015 Guidance
Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease Read more about Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy Read more about Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy
Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel(R) (etanercept) for Patients with Chronic Inflammatory Conditions Read more about Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel(R) (etanercept) for Patients with Chronic Inflammatory Conditions
Amgen Announces Voting Results Of Annual Meeting of Stockholders Read more about Amgen Announces Voting Results Of Annual Meeting of Stockholders
Amgen Receives CHMP Positive Opinion for XGEVA(TM) (Denosumab) in the European Union Read more about Amgen Receives CHMP Positive Opinion for XGEVA(TM) (Denosumab) in the European Union
Amgen Oncology Data to be Presented at ASCO Annual Meeting Read more about Amgen Oncology Data to be Presented at ASCO Annual Meeting
Phase 3 Data Demonstrate XGEVA(TM) (Denosumab) is First Bone Targeted Therapy to Prevent Spread of Cancer to the Bone in Men With Advanced Prostate Cancer Read more about Phase 3 Data Demonstrate XGEVA(TM) (Denosumab) is First Bone Targeted Therapy to Prevent Spread of Cancer to the Bone in Men With Advanced Prostate Cancer
Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference Read more about Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference
Patrick Dempsey Teams up With Breakaway from Cancer(R) to Help Connect Cancer Patients to Free Resources Read more about Patrick Dempsey Teams up With Breakaway from Cancer(R) to Help Connect Cancer Patients to Free Resources
